Overview
Share price change
24h
Current
Min
8.52
Max
9.28
Recommendations | Sell |
|---|---|
12 Months Forecast | -25.29% downside |
Next Earnings | 5 lis 2026 |
|---|
News Sentiment
By Acuity
50%
50%
119 / 339 Ranking in Healthcare
Ginkgo Bioworks Holdings Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
22 wrz 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc is sharply higher on Tuesday, marking a notable break from recent upward momentum observed in prior sessions.
Read
21 wrz 2026, 20:06 UTC
Ginkgo Bioworks Holdings Inc is advancing as the broader market remains higher, maintaining an upward trend and trading above its 20-day moving average.
Read
18 wrz 2026, 20:06 UTC
Ginkgo Bioworks Holdings Inc is seeing modest gains, maintaining a position significantly above its 20-day moving average despite fluctuations earlier in the day.
Read
17 wrz 2026, 20:02 UTC
Ginkgo Bioworks shares rise sharply amid notable call options trading, supported by gains in the ARK Genomic Revolution ETF, despite an earlier pullback.
Read
16 wrz 2026, 19:26 UTC
Ginkgo Bioworks announced a partnership with Eli Lilly's TuneLab to enhance drug development efficiency, as shares fell slightly since Tuesday's close.
Read
15 wrz 2026, 20:07 UTC
Ginkgo Bioworks shares are lower, reflecting broader market declines amid negative economic indicators and rising oil prices. Earlier, shares briefly rebounded before pulling back.
Read
14 wrz 2026, 23:06 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market hours. The broader market faces pressure from rising crude oil prices amid supply concerns.
Read
2 wrz 2026, 19:56 UTC
Ginkgo Bioworks is gaining traction amid social media discussions on Pfizer and Google announcements, despite a generally negative market environment.
Read
1 wrz 2026, 23:06 UTC
Ginkgo Bioworks shares are higher in after-market trading, reaching a peak above the previous day's close. The stock remains below its 20-day moving average.
Read
31 sie 2026, 22:16 UTC
Ginkgo Bioworks Holdings Inc is trading higher in after-market hours, influenced by broader market reactions to comments on inflation and interest rate expectations.
Read
28 sie 2026, 22:02 UTC
Ginkgo Bioworks Holdings Inc shares are higher in after-market trading, continuing a recent trend of daily gains despite no specific news to explain the move.
Read
26 sie 2026, 20:08 UTC
Ginkgo Bioworks Holdings Inc is lower today, influenced by declines in the Life Sciences Tools & Services sub-sector and trading below its 20-day moving average.
Read
25 sie 2026, 20:07 UTC
Ginkgo Bioworks shares advance amid positive sentiment linked to Moderna and Merck. Earlier, shares pulled back from a session high but gained traction.
Read
24 sie 2026, 20:02 UTC
Ginkgo Bioworks shares are lower today amid broader market volatility and geopolitical concerns, with no specific company news identified to explain the decline.
Read
21 sie 2026, 23:56 UTC
Ginkgo Bioworks Holdings Inc is higher in after-market trading amid a broader market rebound, despite no specific company news identified.
Read
20 sie 2026, 23:41 UTC
Ginkgo Bioworks Holdings Inc. gained in after-market trading, supported by broader market movements and positive jobless claims data. Shares remain below their 20-day moving average.
Read
19 sie 2026, 23:51 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading. The stock is also below its 20-day moving average.
Read
17 sie 2026, 19:46 UTC
Ginkgo Bioworks is advancing amid positive market sentiment following a rise in New York manufacturing conditions. Shares pulled back slightly after reaching a session high.
Read
14 sie 2026, 19:46 UTC
Ginkgo Bioworks Holdings Inc shares are lower amid broader market declines following a surprising drop in U.S. retail sales for July.
Read
11 sie 2026, 20:02 UTC
Ginkgo Bioworks shares are lower, tracking the broader market's decline. The stock remains below its 20-day moving average after four consecutive sessions of losses.
Read
10 sie 2026, 19:26 UTC
Ginkgo Bioworks reported second-quarter revenue of $20 million, a 48% decline year-over-year. Shares are trading lower, extending a three-day decline.
Read
7 sie 2026, 22:26 UTC
Ginkgo Bioworks shares decline in after-market hours following TD Cowen's downgrade to Hold and a price target cut to $9.
Read
6 sie 2026, 20:02 UTC
Ginkgo Bioworks is down significantly today, continuing a decline since Wednesday's close, despite recent operational improvements and a brief recovery earlier in the session.
Read
5 sie 2026, 22:51 UTC
Ginkgo Bioworks shares are lower in after-market trading following a revenue miss of $20 million, despite an EPS beat of -$0.92.
Read
4 sie 2026, 19:46 UTC
Ginkgo Bioworks shares are higher today, continuing a four-session rally, supported by broader market trends and easing inflation concerns from falling crude oil prices.
Read
3 sie 2026, 20:04 UTC
Ginkgo Bioworks Holdings Inc. is up notably since Friday's close, reflecting strong performance amid broader market gains, despite a slight pullback earlier in the session.
Read
31 lip 2026, 23:16 UTC
Ginkgo Bioworks shares are lower in after-market hours, reflecting broader market weakness and challenges in the specialty chemicals sector.
Read
29 lip 2026, 19:47 UTC
Ginkgo Bioworks has signed a $2.3 million deal with Thermo Fisher for 11 chips. Shares are declining amid broader market weakness and economic uncertainties.
Read
28 lip 2026, 22:46 UTC
Ginkgo Bioworks Holdings Inc. shares are lower in after-market hours, continuing a downward trend amid broader market weakness ahead of the Federal Reserve's policy meeting.
Read
27 lip 2026, 20:51 UTC
Ginkgo Bioworks shares are higher in after-market hours, supported by broader market trends as European indices, including the DAX, also rise.
Read
Peer Comparison
Price change
Ginkgo Bioworks Holdings Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 7 USD -25.29%
High 9 USD
Low 5 USD
Based on 3 Wall Street analysts offering 12 month price targets forGinkgo Bioworks Holdings Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Sell
3 ratings
0
Buy
1
Hold
2
Sell
Based on 3 analysts giving stock ratings to Ginkgo Bioworks Holdings Inc - Dist in the past 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
$